Kimialys develops reliable, rapid, cost-effective and disruptive diagnostic tests, leveraging a patented surface chemistry applied to standard biosensors, improving their limit of detection by a factor 10 at least while reducing their cost price. This technology is the result of more than 10 years of academic research at the Laboratory of Biology and Applied Pharmacology (ENS Paris-Saclay/CNRS).

Restez informés sur l’actualité de Paris-Saclay SPRING 2019 !

* Requis